Delivery Order SPE2DB24D1205-SPE2DB25FCZUQ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count) valued at $1,640.40, with a firm fixed-price contract type and an ultimate completion date of July 30, 2025. This non-set-aside competitive award was issued on July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within the company's broader federal...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100s) with a ceiling value of $1,222.44 and an ultimate completion date of June 20, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The award was made without set-aside designation, demonstrating...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of OxyContin ER 10 mg tablets (100-count) valued at $3,143.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 7, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $3,009.06 to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This is a firm fixed-price, non-set-aside delivery order issued under a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of OxyContin ER 30 mg tablets (100-count) with a contract value of $1,920.03. The order was competitively awarded on June 18, 2025, with an ultimate completion date of June 20, 2025. This delivery order utilizes firm fixed-price pricing and operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $2,032.21 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) on July 24, 2025, with completion scheduled for July 25, 2025. This competitive award employs a firm fixed price structure with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,988.26 to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count units) on August 6, 2025, with an ultimate completion date of August 7, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) with a ceiling value of $1,768.88. This non-competitive, firm fixed-price delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This delivery order is executed under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,992.89 to AmerisourceBergen Drug Corp for 100 tablets of OxyContin ER 40 mg, with an ultimate completion date of August 11, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement and represents a continuation of the vendor's pharmaceutical supply relationship with the federal government. The place of performance is identified as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,845.42 on August 5, 2025, for the supply of OxyContin ER 20 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 6, 2025, and performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZUQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,166.03 to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count units) with a firm fixed price and an ultimate completion date of August 25, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is part of the company's ongoing provision of comprehensive pharmaceutical products and medical supplies to support military and federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive portfolio of federal contracts with DLA covering a wide range of therapeutic domains, from specialty medications to vaccines and medical devices. The award demonstrates the company's continued capability to meet federal procurement requirements for critical pharmaceutical commodities through the DLA's Medical Supply Chain, which serves customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/22/25 |